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SES Reduce In-Stent Restenosis in SVGs
Previous randomized studies comparing sirolimus-eluting stents (SES) tobare-metal stents (BMS) have excluded lesions in saphenous vein grafts,
yet these lesions have higher rates of restenosis compared to native vessels. The
RRISC (Reduction of Restenosis In Saphenous vein grafts with Cypher stent)
trial randomized 75 subjects to either SES or BMS in a double-blind fashion
with mandated follow-up angiography at 6 months. Binary in-stent restenosis
was reduced from 30% to 10% when using SES. This study suggests that the
risk of in-stent restenosis is high in SVGs, but can be substantially reduced
through the use of SES. See page 2423.
Page 2465
Postinfarction
Myocardial Perfusion Imaging
Questioning the Routine Invasive Paradigm
Deciding which patients should proceed directly to angiography remainschallenging as both medical therapy and revascularization success con-
tinue to evolve. The INSPIRE (Adenosine Sestamibi Post-Infarction Evalua-
tion) trial is a large multinational study with 2 main aims. The first aim was to
determine if single-photon emission computed tomography (SPECT) imaging
can identify low risk post-myocardial infarction (MI) patients who can be
discharged early. One-third of patients were classified as low risk with small
(20%) perfusion defects, preserved left ventricular function and 10%
residual ischemia. The 1-year risk of death or reinfarction was 2% in this
group. The second aim of this study was to compare aggressive anti-anginal
medical therapy with revascularization in a higher risk group in which patients
had large total (20%) and ischemic (10%) perfusion defects, but an
ejection fraction 35%. Both medical therapy and revascularization resulted
in an approximately 20% reduction in perfusion and ischemic defects after 2
months with similar clinical outcomes. These 2 related trials offer support to
strategies that do not mandate routine invasive strategy. See pages 2448,
2458, and 2468. See figure.
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Heart Failure
Iron Deficiency Underestimated in CHF Patients With Anemia
Several recent studies have found higher mortality in patients with congestive heartfailure (CHF) who are anemic, with an approximate 3% increase in mortality for
every 1% decrease in hematocrit. Nanas and colleagues performed extensive analyses
on 37 patients with anemia and decompensated heart failure. The analyses included
not only serum measures of iron, ferritin, and erythropoietin, but also bone marrow
biopsies. Iron deficiency anemia was confirmed by bone-marrow aspiration in 73% of
patients and 5% had dilutional anemia. No specific cause was identified in 19%, who
were considered to have “anemia of chronic disease.” Neither serum ferritin nor serum
iron levels reliably identified iron-deficient patients. While the etiology of anemia in
heart failure is complex, this study suggests that iron deficiency is prevalent and a trial
of iron therapymaybe considered even if serum iron and ferritin levels are normal.See
pages 2485 and 2490. See figure.
(continued) A-48Heart Rhythm Disorders
Long-Term Follow-Up of Pulmonary Vein Stenosis After AF Ablation
In a previously published study, Di Biase and colleagues found that approximately1% of patients had at least one pulmonary vein (PV) occlude after PV isolation
procedures. In this report, long term follow-up of 18 patients is reported. Using serial
computed tomography scans, most patients were asymptomatic if only one PV was
occluded as long as the other PV for that lung had a50% stenosis. For those with
stenoses of both PVs nuclear perfusion scans demonstrated decreased lung perfusion
which also correlated with patient symptoms and response to opening of the blockage.
In this study, patients with a single pulmonary vein occlusion (PVO) are mostly
asymptomatic, but in patients with concomitant ipsilateral pulmonary vein stenosis/
PVO, interventions to restore pulmonary flow and prevent associated lung disease
should be considered. See page 2493.
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Cardiac Imaging
Head-to-Head Comparison of MDCT and MPI
Multi-slice computed tomography (MSCT) is able to accurately determine thepresence or absence of coronary stenoses when compared to coronary angiog-
raphy, but does not provide data on myocardial perfusion. Schuijf and colleagues
performed MSCT in 114 patients referred for nuclear myocardial perfusion imaging
(MPI) studies; one-half of these patients subsequently underwent coronary angiogra-
phy. Ninety percent of patients with no lesions on MSCT had a normal MPI. When
theMSCTwas abnormal, it was 50-50 whether theMPI would also be abnormal, yet
the MSCT showed excellent correlation with subsequent angiography. The authors
conclude that MPI andMSCT provide different and complementary information on
coronary artery disease, namely detection of atherosclerosis versus detection of isch-
emia. An editorial by Dorbala and colleagues comments on how MSCT may be
incorporated into diagnostic algorithms in the future. See pages 2508 and 2515.
See figure.
